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ABSTRACT 
 
Aim: To explore whether Video-Shared Medical Appointments (video-SMA), where group 
education and medication titration were provided remotely through video-conferencing 
technology would improve diabetes outcomes in remote rural settings.  
Methods: We conducted a pilot where a team of a clinical pharmacist and a nurse practitioner 
from Honolulu VA hospital remotely delivered video-SMA in diabetes to Guam. Patients with 
diabetes and HbA1c ≥7% were enrolled into the study during 2013-2014. Six groups of 4-6 
subjects attended 4 weekly sessions, followed by 2 bi-monthly booster video-SMA sessions for 5 
months. Patients with HbA1c ≥7% that had primary care visits during the study period but not 
referred/recruited for video-SMA were selected as usual-care comparators. We compared 
changes from baseline in HbA1c, blood-pressure, and lipid levels using mixed-effect modeling 
between video-SMA and usual care groups. We also analyzed emergency department (ED) visits 
and hospitalizations. Focus groups were conducted to understand patient’s perceptions.  
Results: Thirty-one patients received video-SMA and charts of 69 subjects were abstracted as 
usual-care. After 5 months, there was a significant decline in HbA1c in video-SMA vs. usual-
care (9.1±1.9 to 8.3±1.8 vs. 8.6±1.4 to 8.7±1.6, P=0.03). No significant change in blood-pressure 
or lipid levels was found between the groups. Patients in the video-SMA group had significantly 
lower rates of ED visits (3.2% vs. 17.4%, P=0.01) than usual-care but similar hospitalization 
rates. Focus groups suggested patient satisfaction with video-SMA and increase in self-efficacy 
in diabetes self-care. 
Conclusion: Video-SMA is feasible, well-perceived and has the potential to improve diabetes 
outcomes in a rural setting.  
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Abbreviations: 
 
ACE-inhibitor = Angiotensin converting enzyme - inhibitor 
ARB = Angiotensin receptor blocker 
CBOC = Community-based outpatient clinic 
DM = Diabetes Mellitus 
ED = Emergency Department 
PACIC= Patient Assessment of Care in Chronic Conditions  
VAMC = Veterans Affairs Medical Center 
VHA = Veterans Health Administration  
video-SMA = video-Shared Medical Appointments 
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1. INTRODUCTION 
 
The burden of diabetes mellitus significantly impacts quality of life, as well as, economics for 
persons with diabetes and the healthcare system.  Recent meta-analyses showed that 
multifactorial risk factor control reduces complications in diabetes without an increased risk of 
death, thus highlighting the importance of achieving guideline recommended goals for glycemic, 
as well as, hypertension, hyperlipidemia to reduce morbidity and mortality1. Quality 
improvement strategies to reduce the burden of diabetes advocate for a concomitant 
multifactorial therapy 2.  This must include vigorous behavioral and pharmacologic interventions 
which are labor intensive, costly 2, and difficult to accomplish in the traditional care settings 3-5.  
Shared medical appointments (SMA’s) are an innovative interdisciplinary model in improving 
care for chronic diseases including diabetes care 6-11. SMA’s are defined as group visits in which 
several patients meet with one or more provider(s) at the same time 8-15.  In the group visit 
intervention, the SMA providers deliver interactive discussions to shape values that the person 
places on a given outcome in an environment of peer support.  During the SMAs, the facilitator 
uses group dynamics to promote observational and experiential learning, provide reinforcement 
for healthy behavior, and foster diabetes self-management to promote self-efficacy 10-12,16-19.  
Thus, SMAs may well be an efficient method to achieve guideline recommendations in diabetes 
through efficient resource use, improvement of access to care, and promotion of behavioral 
change 16-18,20,21 with peer support 8-12,19,21.  It is also an ideal setting to activate patients and 
induce change in self-management behaviors 8,9,12,13,22.   
 
Yet, the spread and access to these services are limited in rural areas due to lack of healthcare 
specialists and skill sets to conduct SMA’s 23-25. The challenges of health-care delivery in rural 
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areas are social and geographic isolation, limited access to multi-disciplinary expertise, lack of 
decision support and inter-professional exchange for the local providers 11,23,24,26.  These socio-
geographic barriers may be overcome by video-teleconferencing technology for real-time SMA 
(video-SMAs) between a distant provider and the local patients. Telemedicine is defined as the 
delivery of healthcare services using video-conference technology.27 Given the recent advances 
in the delivery of health care through video-conference technology in the Veterans Health 
Administration (VHA)28, this pilot study intends to explore the feasibility of innovative modes of 
care delivery, such as video-SMA, to improve DM care at remote clinical sites lacking local 
expertise. 
 
2. MATERIALS AND METHODS  
 
2.1 Study Design 
 
Setting: This study targets the socio-geographic barriers in rural diabetes care using the Honolulu 
VAMC video-conferencing technology to deliver video-SMA to the Guam Community-based 
outpatient clinic (CBOC). The western most U.S. territory of Guam is a 210-square-mile tropical 
island, 3,950 miles from Hawaii. Guam has a shortage of health care professionals and presently 
has only one public hospital and a Naval hospital for acute care. 
 
This pilot consisted of a prospective non-randomized study where a target of 100 patients with 
chart documented diabetes and HbA1c ≥7%, and were seen by their primary care provider during 
the study period were recruited. Given the short time-frame of 5 months, only thirty-one patients 
were recruited to participate in the video-SMA program (Figure 1). Written informed consent 
was obtained from each video-SMA participant. The remaining 69 subjects with diabetes who 
attended Guam CBOC for primary care during the same period of time served as the usual care 
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comparator group. A waiver of informed consent was approved to review the time-matched usual 
care participants’ data. The Institutional Review Board and Research and Development 
Committees at the Honolulu VAMC and Providence VAMC (coordinating site) approved the 
protocol. All study procedures were conducted in accordance with the ethical standards of the 
Helsinki Declaration of 1975. Enrollment for this study began in January, 2013 and ended in 
February, 2014.   
2.2 Study Population 
Patient enrollment in both groups is shown in Figure 2. Patients were eligible if they had 
documented diabetes and HbA1c ≥7%, or were referred by their primary care providers to assist 
in diabetes care. Patients were excluded from the study if they were unable or not willing to 
participate in the video-SMA. Patients for the usual care group were selected from the Guam 
Veteran population with the same criteria of a baseline HbA1c ≥ 7%.  A total of 69 usual care 
patients were consecutively selected for a total of 100 patients in the study. 
 
Time 0 for the intervention group occurred at the time of the first video-SMA, while for usual 
care, the first primary care visit within the study period. Study duration was 5 months for all 
patients.  
2.3 Intervention 
Participants received 4 weekly video-SMA group sessions (3-5 patients per group) followed by 2 
bi-monthly booster video-SMA visits for a total duration of 5 months (a total of 6 sessions). Each 
session was 120 minutes. Additionally, family members, friends or social support were 
encouraged to participate in the sessions. A nurse practitioner and clinical pharmacist at the 
Honolulu VAMC facilitated these sessions through video-teleconferencing to participants at the 
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Guam CBOC.  Both facilitators were diabetes core content experts and certified as diabetes 
educators. The sessions consisted of education with behavioral and pharmacological 
interventions for diabetes, hypertension, and hyperlipidemia. The education included interactive 
lectures and use of conversation maps that were based on the American Diabetes Association 
(ADA) standards of diabetes self-management. Each session focused on one or two of the core 
diabetes content areas such as healthy eating or physical activity. During the video-SMA, 
participants were given an individualized cardiovascular risk report card that contained their 
current vitals and laboratory values. These report cards were updated with lab results, such as 
HbA1c and lipid panel, at the 1 month, 3 month, and 5 month visits. Medications for diabetes, 
blood pressure, and lipids were initiated or titrated according to their report cards, based on the 
national VHA diabetes guidelines, and the VHA national formulary. Individualized plans 
regarding diet, exercise, medication, and self-monitoring of blood pressure or blood glucose 
levels were given to patients at each visit. Each participant provided input for their behavioral 
modification goal to ensure that these met the patient’s needs and was appropriate for patient’s 
self-care abilities. Telephone follow-up visits were provided on an “as needed basis” to 
participants in regards to self-monitoring, management skills, and/or laboratory values and 
occurred on an average of once-twice monthly. Each video-SMA participant completed a 
voluntary Patient Assessment of Care in Chronic Conditions (PACIC) survey after the initial 
weekly sessions and also attended a focus group which was centered on understanding the 
obstacles patients faced in caring for their diabetes, as well as, assessing the perceived efficacy 
of video-SMAs. 
 
2.3.1. Usual Care 
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Given geographical isolation leading to limited access to subspecialist physicians and health 
professionals of other disciplines, usual care for individuals with diabetes in Guam CBOC 
consisted of regular individual visits with primary care physician every 4 to 6 months. There was 
no access to shared medical appointments, clinical pharmacists and/or nurse practitioners; and 
family members, friends or social support were not specifically invited to be involved in the 
physician office visits. Telephone follow-up did not routinely occur in usual care. 
 
2.4 Measurements and Outcomes 
Medical/social history and medications were collected through chart review. 
Quantitative Outcomes 
The primary outcome of this study was to assess changes from baseline in HbA1c measured at 5 
months. The secondary outcomes included changes in blood pressure and fasting lipid values 
(LDL-c, triglycerides) in the same time frame.  Blood pressure was measured using the standard 
methodology by clinical staff with the participant in the seated position using an automatic 
electronic cuff.  HbA1c and lipid tests were performed in a Clinical Laboratory Improvement 
Amendments (CLIA)-accredited laboratory at the U.S. Naval Hospital Guam. Our third outcome 
of interest was ED visits and hospitalizations, which were recorded through chart review.  
Qualitative Outcomes 
Patients: The PACIC survey29 was administered for each video-SMA group at either week 3 or 4 
of the video-SMA sessions. The PACIC is a well validated 20-item questionnaire, scored 1-5 for 
each question (1 for “none of the time”, 2 for “a little of the time”, 3 for “some of the time”, 4 for 
“most of the time” and 5 for “always”) and is a measure for concordance of care with the tenets 
of the chronic care model and has 5 subscales: Patient Activation, Delivery System 
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Design/Decision Support, Goal Setting, Problem-solving/Contextual Counseling, Follow-
up/Coordination. The overall scale and the various subscales were internally consistent and 
moderately stable during test-retest.29 Given abnormal distribution, PACIC scores are presented 
as the median and [interquartile range]. 
 
Focus groups were conducted by a clinical pharmacist (TT) and a nurse (LM) from Providence 
VA with expertise in the conduction of SMAs, one week after the PACIC survey administration. 
Focus groups were conducted only with those participants who were willing to stay after their 
video-SMA intervention.  The focus groups were informed by the patients’ responses to the 
PACIC surveys and input was elicited from the participants about the facilitators, barriers to 
diabetes self-management and perceived reasons for non-adherence to healthy behaviors. The 
level of satisfaction with the program and overall diabetes care at the VA were solicited from the 
participants to determine in what ways, the video-SMA helped or did not help them in their 
diabetes.  
 
Provider: The video-SMA providers (clinical pharmacist and nurse practitioner) from Honolulu 
VAMC were interviewed after the intervention to elicit input about health system barriers to 
diabetes care, and how video-SMA may or may not have overcome those barriers. The 
interviews also focused on provider’s attitudes and satisfaction about the video-SMA’s as a 
mode of care delivery and whether they believe the video-SMA’s helped provide better diabetes 
care.   
2.5 Statistical Analyses 
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Continuous data were presented as mean and standard error of the mean (SE), whereas 
categorical variables presented as percentages. Baseline characteristics were compared using 
two-sample T-test with unequal variance for continuous variables and Pearson chi square test for 
categorical variables. Comparison of the change from baseline in HbA1c, lipids, and blood 
pressure values between the video-SMA and usual care groups were analyzed by linear mixed 
effects modeling which accounts for differences in baseline values, where the fixed effects are 
the study time period (baseline or 5 months), video-SMA intervention (or usual care) and time-
period*video-SMA interaction, with the study subject being the random effect variable to 
account for multiple correlated measures  within the same subject. Adjustments for baseline 
characteristics were made when significant imbalances existed in baseline characteristics 
between study groups were found. No significant differences between the intervention and 
control arm were found in baseline characteristics except for diastolic blood pressure which was 
accounted for in the linear mixed model. Comparisons between number of hospital admissions 
and non-hospitalization ED visits were also made using chi-square tests. Analyses were 
performed using the Stata SE version 11.0 (Stata Corp, College Station, TX). All P values were 
two-sided and a P≤0.05 was considered significant. 
 
3. RESULTS 
 
3.1 Baseline Characteristics 
Thirty-one patients (divided into 6 cohorts) received video-SMA intervention and charts of 69 
patients in usual care were abstracted for a total of 100 patients in the study. Amongst the video-
SMA participants, 87% of them attended at least 5 of the 6 sessions of video-SMA visits. As 
shown in Table 1, overall mean age in both groups was 61 years, 95% were males, and 63% 
were Asian/Pacific Islander. At the time of study enrollment, most patients had diabetes duration 
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<10 years. Aside from a 5 mmHg difference in diastolic blood pressure, other variables were 
similar between the two groups. 
3.2 Video-SMA and HbA1c Levels  
The change from baseline value in HbA1c for patients in the video-SMA group was significantly 
greater than the usual care group (9.1 ±0.3 to 8.3 ±0.3 vs. 8.6 ± 0.2 to 8.7 ±0.2, respectively, P = 
0.03, Table 2). As described in Figure 3, the greatest decline in HbA1c values in the video-SMA 
group was observed after 1 to 3months. 
3.3 Video-SMA and Blood Pressure and Lipid Levels  
In regards to blood pressure, patients in the video-SMA group had significant decreases in both 
systolic (P=0.01) and diastolic blood pressures (P=0.04) from baseline, but not the usual care 
group (Table 2). However, the differences in the change from baseline in blood pressure were 
not significantly different between the video-SMA intervention and usual care groups (P = 0.15 
for systolic and P = 0.12 for diastolic blood pressures). 
 
Similar to blood pressure, differences in the change from baseline in LDL cholesterol or 
triglyceride levels were not significantly different between the video-SMA intervention and 
usual care groups (LDL: P = 0.55; Triglyceride: P = 0.75; Table 2).  
3.4 Video-SMA and Healthcare Utilization 
Patients in the video-SMA-intervention group showed a lower rate of ED visits relative to the 
usual care group (3.2% vs. 17.4%, P=0.01), but the hospitalization rates were similar between 
the two groups (3.2% vs. 2.9%, P=0.64).  
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Patients in the video-SMA-intervention group had a trend towards higher prescription rates of 
metformin (80.6% in video-SMA vs. 60.8% in control, p=0.052) and ACE Inhibitors/ARB 
(93.5% in video-SMA vs. 79.7% in control, p=0.08), while the prescription of statins, 
sulphonylurea and insulin were similar between the study arms (Table 5). 
3.5 Qualitative Results: 
Patient Assessment of Care in Chronic Conditions (PACIC) Survey:   
Of the 31 patients in the video-SMA intervention, 19 participants agreed and completed the 
PACIC survey. Data was complete for 89% (17/19) of the surveys (Table 4). The median 
[interquartile range] of the PACIC summary score was 4.5 [4.1 to 4.6] indicating a perceived 
concordance with the tenets of the chronic care model in the “most of the time” to “always” 
range.  There were slight differences between the different PACIC subscale scores.  The subscale 
score for “follow-up/care coordination” resulted the lowest with a median score of 4.0 [3.3 to 
4.5], corresponding to a rating of “a little of the time” to ‘‘most of the time’’ range.  The highest 
subscale score was “problem-solving/contextual counseling” with a median subscale score of 4.8 
[4.0 to 5.0], corresponding with a rating of slightly lower than “always” (Table 4). 
 
Focus Groups: 
Patients: Of the 31 patients in the video-SMA group, 15 patients and 2 members of social 
support participated in 4 focus groups. Six themes emerged:  1) overall satisfaction with the 
video-SMA experience, 2) patients feeling that the information provided was informative and 
personally beneficial, 3) improved awareness of the importance of social support in diabetes, 4) 
improvement in self-efficacy to perform self-care behaviors, and 5) an increased concern over 
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health and life expectancy, 6) satisfaction with the cultural competency of the video-SMA 
providers and the use of culturally appropriate educational materials. 
 
The first theme of satisfaction with the group was present in all 4 of the focus groups.  Overall, 
patients expressed enjoyment of the video-SMA visit and reported that it helped them manage 
their condition.  Examples of quotes are: “I found it informational…I learned a lot about my 
diabetes and what I need to do to prevent complications”, “the providers answer all my 
questions and explain to me what is happening and why”, and “I think there is a great need for 
something like this for everyone”.   
 
Patients also acknowledged that they were satisfied with their clinical care and management. 
Examples include: “Everyone seems like they really care about us and are concerned and, want 
us to take care of ourselves…,” and “…she [the video-SMA provider]  is very good., and she is 
a smart lady and knows about all the foods we eat and how it is over here” …” 
 
Two participants however, provided recommendations for program improvement.  The first 
participant expressed that he would prefer to have more “individual time” with the video-SMA 
providers to discuss his personal diabetes concerns such as “mental health issues that affect the 
way I take care of my diabetes” and another participant expressed frustration with members of 
the group who were allowed to “get off track too much”. 
 
The second theme was patients feeling that the information provided was informative and 
personally beneficial.  Patients acknowledged an increase in knowledge stating: “I learned about 
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what my goals are, how often I should be checking my sugars and what can happen if I don’t 
take care of it [diabetes]”, and “…they talked about diet, you know, carbohydrates, exercise, all 
the other things you’re supposed to do if you have diabetes”.   
 
The third theme was improved awareness of the importance of social support in diabetes.  When 
they were asked the question about whether or not other members of the group helped them take 
care of their diabetes, patients’ responses indicated they learned a lot from others in the group 
and that peer interaction and support was beneficial: “I learned a lot about what other people are 
doing for their diabetes”, and “This guy told me about what was going to happen to me if I don’t 
do what I am supposed to do”.  Several participants also shared that it was comforting to know 
that “they weren’t alone”, or “other people have the same problems as me”.   
 
The fourth theme was improvement in self-efficacy to perform self-care behaviors. This is 
especially important since the participants also expressed lack of self-control over dietary habits 
and lack of confidence to manage their own diabetes. Patients in the video-SMA group expressed 
increased motivation for self-care behavior change or improvement in self-care skills: “The 
sessions are making me more responsible.  I know that someone is going to be checking me and 
all the other guys will have their stuff done so I have to get it done too”, “Now, I know how 
many times I should be checking [blood glucose] and what to do about it…” and“…Now I know 
how important it is to take all my medications”.   
 
The fifth theme was an increased concern over health and life expectancy.  Patient expressed that 
“now that I know what can happen if I don’t eat right and take my medications” and “now that I 
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know all the problems that I can have with my feet, eyes and heart I am going to be more 
careful”. 
 
The final theme was satisfaction with the cultural competency of the video-SMA providers and 
the use of culturally appropriate educational materials. Patients made statements such as “She 
[the video-SMA provider] knows it is different over here. We have our [customary] barbecues 
and everyone tells you to eat, eat! It is hard to say no…” and “…the food we have is different, 
we have our poi poi and we make our food different; she knows that” 
 
Providers: The video-SMA providers were interviewed after the video-SMA intervention. Four 
themes emerged from the semi-structured interviews:  1) Overall satisfaction with the video-
SMA experience, 2) Perceived benefits for their patients 3) Health system barriers to diabetes 
care and potential resolutions for these barriers and 4) Effective video-SMA facilitation 
strategies and key elements. 
 
The first theme of overall satisfaction with the video-SMA experience was endorsed by both 
providers.  Both providers expressed that “it was very rewarding to see challenging, high-risk 
patients become better self-managers, teachers and motivators for other patients, as well as have 
improved clinical outcome measures after participation in video-SMA”.    
 
The second theme was the perceived benefit of peer support for their patients.  The video-SMA 
providers acknowledged that peer support contributed to the improvements in patient outcomes 
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and stated “with team guidance, patients learn from each other about solutions to tackle the day-
to-day challenges in a way that is impossible to achieve in traditional individual clinic visits”. 
 
The third theme was perceived health system barriers and potential resolution for these barriers.  
Both providers acknowledge that the physical distance (Honolulu to Guam) and lack of 
personnel dedicated to video-SMA activities along with an overburdened support staff initially 
posed challenges to care delivery at the intervention site. The physical distance and mail delivery 
from a VHA central filling pharmacy often created a lag time for medication delivery, making it 
difficult to initiate new medication therapies.  Therefore, the video-SMA providers worked with 
the intervention site to increase their cache supply of medications relevant to diabetes care.  
Since the tele-communication system on the island of Guam is inconsistent it was often difficult 
for Honolulu providers to call patients to obtain blood glucose values.  The video-SMA 
providers partnered with the intervention site provider to obtain blood glucose readings during 
interim care visits in order to titrate medications accordingly. Finally, the lack of support staff 
dedicated to video-SMA activities created delays in obtaining vital signs prior to the video-SMA 
appointment.  Negotiation and partnership with local providers at the intervention site increased 
dedicated time of local personnel to video-SMA related activities and re-prioritization of 
workload, resulting in decreased delays during sessions.   
 
The final theme discussed was the effective video-SMA facilitation strategies and key 
components to maximize patient interaction in the group setting while participating in video-
SMA communication.  The providers identified that the use of interactive games and patient 
education tools such as diabetes report cards and standardized self-monitoring forms were 
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essential to promote interactive discussions among participants.  Also, the video-SMA providers 
underscored the importance of cultural competency stating that it was “critical that we [the 
video-SMA providers] were sensitive and expressed a value for diversity; that we were 
conscious of the dynamics inherent to the participant’s cultures especially in the group 
interaction and demonstrated that we [the video-SMA providers] had knowledge regarding these 
differences and were willing to adapt our service delivery to reflect an understanding of cultural 
diversity”. 
 
3.6. Working collaboration between the clinical pharmacist and the nurse practitioner 
 
The pharmacist and the nurse practitioner were in the same room during the SMAs where they 
complement their different expertise to manage diabetes and counsel the patients on a variety of 
topics in diabetes self-care. The pharmacist’s emphasis was in medication management, 
adherence and side effects; while the nurse practitioner’s emphasis was on clinical signs and 
symptoms of comorbid conditions or complications of diabetes, interpretation of test results and 
the need for referral to other clinical specialists. In addition, both providers were able to initiate 
or adjust medications for diabetes, hypertension and lipids. 
 
4. DISCUSSION 
In a prospective, non-randomized study with concomitant historical controls, we showed that 
video-SMA in diabetes, delivered remotely through video conferencing technology, was feasible, 
well perceived by the patients and providers, and associated with a significant decline in HbA1c 
compared to the usual-care comparator. Additionally, patients in the video-SMA group had 
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significantly lower rates of ED visits (3.2% vs. 17.4%, P=0.01) compared to the usual-care, but 
with similar hospitalization rates.  
 
Although previous studies have shown the efficacy of SMAs in improving glycemic and blood 
pressure control,16-18,20,21 these SMAs have been conducted in the concomitant physical presence 
of both the providers and the patients. Thus, the feasibility and efficacy of SMAs in diabetes 
delivered through video-conferencing technology is unknown. This study represents the first 
steps to show that this novel mode of care delivery is feasible and possibly efficacious. In 
addition to the overall satisfaction with the video-SMA experience, our patient focus groups 
suggested that the overarching goals of education, medication titration and peer support were 
achieved and there appeared to be improvement in the self-efficacy to perform self-care for these 
patients with diabetes. There were also trends toward higher prescription of guideline 
recommended therapy for diabetes such as metformin and ACE inhibitors/ARB. These are likely 
contributory factors through which the improvement in HbA1c and reductions in ED visits were 
observed. On the other hand, the highest impact of video-SMA’s on HbA1c was seen after the 
four weekly sessions up to month 3, after which the patients get a bi-monthly booster session, 
where we found HbA1c values had started to rise again.	  This finding would suggest that it takes 
frequent video-SMA support to inculcate diabetes self-management and to maintain glycemic 
control on the long term. Potential implications of the above would favor the use of non-
physician providers as suggested by this study for sustainability of the program and control of 
cost. 
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Aside from usual barriers to diabetes self-management such as lack of self-control over dietary 
habits and lack of personal control over how to manage their diabetes,30 there are also unique 
barriers to diabetes self-management in diabetic patients in Guam. There is generally a low 
physical activity level and a lack of fruits and vegetables in their diet in the lifestyle habits of 
people in Guam.31,32 In addition, geographic isolation may also result in limited access to 
qualified personnel to provide diabetes self-management education as well as medication and 
testing supplies in a consistent fashion (focus groups). Thus, the potential impact of 
implementation of the video-SMA initiative in rural areas, such as Guam, could facilitate 
diabetes care and self-management by: 1) improving access to providers experienced in diabetes 
management for monitoring and reinforcement of diabetes self –care behaviors; 2) providing 
multi-disciplinary diabetes care to educate about multiple aspects of diabetes self-management; 
3) training local health care personnel and help rural sites meet quality standards for diabetes 
care and 4) providing peer support for diabetes self- management. Video-SMA’s may enable 
patients residing in rural areas to receive a similar level of care for their diabetes from remote 
providers of distant clinic or hospital facilities without the inconvenience and expenses of 
traveling to those distant sites. These results also shed light on the program capacity for planning 
of future large scale implementation trials. In this case, a team of a clinical pharmacist and a 
nurse practitioner were able to complete 6 video-SMA groups of 31 participants in a short 
duration of 5 months with good results.  
 
However, we also noted that video-SMA did not completely fulfill the health care needs of the 
patients with diabetes (theme from focus groups), and there was the need for individual time with 
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the video-SMA provider and possibly frequent visits, which may be an important facet to 
incorporate in the future design. Another aspect of the theme from the focus groups was the 
importance the patients placed on the cultural competency of their health care providers. In this 
case, the video-SMA providers from Honolulu were well-versed with the idiosyncrasies of the 
local culture, especially food, as well as the use of culturally appropriate educational materials, 
which may explain in part their success with achieving good diabetes outcomes. 
 
From the provider perspective, although there were system barriers such as lack of dedicated 
support for the video-SMA patients and communication challenges with patients (lack of a 
consistent telecommunication system), many of these barriers were overcome and there was 
overall satisfaction and perceived benefit of this video-SMA intervention.  In contrast, we did not 
see significant differences in blood pressure between the two groups despite significant 
reductions in blood pressure in the video-SMA patients. The likely reason for this discrepancy is 
the small sample size of this pilot which limited statistical power. Similarly, significant 
differences in reduction of lipid parameters were not detected. In addition to sample size, other 
possible reasons for similar lipid outcomes between video-SMA and usual care could include 
relatively low LDL levels at baseline which limits room for improvement, and the improvement 
in lipid values in both arms. 
 
On the other hand, the results of this trial should also be considered preliminary as potential 
limitations are: 1) its small sample size and the enrollment of mostly men (reflective of the 
gender composition of U.S. military veterans), which may limit generalizability; 2) the quasi-
experimental design which may be prone to selection bias, despite that baseline characteristics 
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appeared to be balanced between the treated and usual-care groups; and 3) the unique setting in 
Guam and Honolulu sites with electronic medical records and video-conferencing capacity 
which may limit expansion to programs without a similar set up. Given the pilot nature of the 
study without an attention control arm, it is also possible that our findings can be explained by 
paying more attention to patients included in the video-SMA group than to patients in the usual-
care group. Nonetheless, we showed that the program is feasible, associated with a significant 
decline in HbA1c and with high patient and provider satisfaction; therefore, justifies a larger, 
multi-site randomized-control trial to further confirm these preliminary findings.   
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SUMMARY POINTS 
 
• Multifactorial behavioral and pharmacological interventions for cardiovascular risk 
reduction are necessary to reduce complications, but are difficult to accomplish in 
traditional care settings.  
• Shared medical appointments (SMA’s), defined as group visits in which several patients 
meet with one or more providers at the same time, are an innovative interdisciplinary 
model to target multiple risk factors in the same setting for chronic diseases including 
diabetes but may be difficult to deliver in rural setting given limited resources and 
availability health care providers. 
• This prospective, non-randomized study with concomitant historical controls, showed 
that video-SMA in diabetes, delivered remotely through video conferencing technology, 
was feasible, well perceived by the patients and providers, and associated with a 
significant decline in HbA1c compared to the usual-care comparator. 
• Video-SMA to improve DM care may also lower rates of emergency department visits, 
but does not impact rates of hospitalization.  
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TABLE 1 Baseline Characteristics 
 
 
Usual Care 
 
Video-SMA 
Intervention 
 
P value 
N 69 31 - 
Age (mean ± SE, years) 61.6±1.1 60.4±1.4 0.48 
Asian/Pacific Islander (%) 71 55 0.17 
Male (%) 89.9 100 0.07 
Weight (mean ± SE, kg) 93.5±2.1 95.9±4.2 0.61 
Duration of diabetes (%) 
 
≤5 years…………........... 
6-10 years……………..... 
>10 years…………....... 
 
 
 
30.4 
30.4 
39.1 
 
 
16.1 
34.4 
48.4 
0.32 
Smoker, current (%) 34.8 32.3 0.80 
Coronary Artery Disease 
(%) 43.5 38.7 0.66 
Stroke (%) 10.1 6.5 0.55 
Hypertension (%) 95.7 96.8 0.92 
Systolic Blood Pressure 
(mean ± SE, mmHg) 135.1±1.9 141.8±3.0 0.07 
Diastolic Blood Pressure 
(mean ± SE, mmHg) 75.0±1.4 80.8±2.2 0.03 
HbA1c (mean ± SE, %) 8.6±0.2 9.1±0.3 0.21 
Total cholesterol  
(mean ± SE, mmol/L) 4.4±0.1 4.5±0.2 0.68 
Triglycerides  
(mean ± SE, mmol/L) 2.2±0.2 2.6±0.7 0.57 
LDL-cholesterol 
(mean ± SE, mmol/L) 2.4±0.1 2.4±0.2 0.95 
Insulin, all forms  (%) 52.1 51.6 0.96 
Metformin (%) 66.6 74.2 0.44 
Sulphonylurea (%) 37.6 48.3 0.32 
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Statin (%) 79.7 77.4 0.80 
ACE Inhibitors/ARB (%) 88.4 87.0 0.86 
ACE= angiotensin-converting enzyme;  SE = Standard error of the mean; ARB = 
Angiotensin receptor blocker  
Bold = Significantly different between video-SMA and usual care groups.   
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          TABLE 2 Effect of Video-SMA on HbA1c, Blood Pressure, and Lipid Levels.  
 
Outcomes 
(mean ± SE) 
Usual Care 
 
Video-SMA intervention 
 
P Value for 
comparison between 
video-SMA and 
Usual care N Baseline 5 month N Baseline 5 month 
HbA1c (%) 69 8.6±0.2 8.7±0.2 31 9.1±0.3 8.3±0.3 0.03 
Systolic Blood 
Pressure 
(mmHg) 
67 135.1±1.9 131.5±1.5 31 141.8±3.0 132.6±3.2* 0.15 
Diastolic 
Blood 
Pressure 
(mmHg) 
67 75.0±1.4 74.3±1.3 31 80.8±2.2 75.8±1.8* 0.12 
LDL-
cholesterol 
(mmol/L) 
69 2.4±0.1 2.3±0.1 31 2.4±0.2 2.2±0.2 0.55 
Triglycerides 
(mmol/L) 69 2.2±0.2 2.4±0.3 31 2.6±0.7 2.1±2.3 0.75 
*P<0.05 compared to baseline 
SE = Standard error of the mean  
Bold = Significantly different between video-SMA and usual care groups.   
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TABLE3 Effect of video-SMA on Emergency Department and Hospital Visits 
 
 USUAL CARE 
(N = 69) 
Video-SMA 
INTERVENTION 
(N = 31) P 
Value 
Number of Events  
(%) 
Number of Events  
(%) 
Emergency 
Department 
Visits* 
16 
(17.4) 
 
1 
(3.2) 
 
0.01 
Hospitalizations 4 
(2.9) 
 
1 
(3.2) 
 
0.64 
Bold = Significantly different between video-SMA and usual care groups.   
*Did not result in hospitalization.  
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TABLE 4. Patient Assessment of Care in Chronic Conditions (PACIC) Score from Participants 
in the Focus Groups 
 
 
PACIC Domains N Median Interquartile 
Range 
Patient Activation 19 4.3 3.7 to 5.0 
Delivery System/Decision Support 19 4.7 4.0 to 5.0 
Goal Setting/Tailoring 19 4.4 4.0 to 4.8 
Problem Solving/Contextual 
Counseling  
18 4.8 4.0 to 5.0 
Follow-up/Coordination 17 4.0 3.3 to 4.5 
PACIC SUMMARY SCORE 17 4.5 4.1 to 4.6 
PACIC = Patient Assessment of Care in Chronic Conditions 
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TABLE 5. Diabetes and Lipid-Related-Medications at 5 Months from Baseline  
 
  
 Usual Care  
Video-SMA 
Intervention 
 
P value 
N 69 31 - 
Insulin, all forms  (%) 56.5 61.3 0.65 
Metformin (%) 60.8 80.6 0.052 
Sulphonylurea (%) 37.7 51.6 0.19 
Statin (%) 79.7 83.8 0.62 
ACE Inhibitors/ARB (%) 79.7 93.5 0.08 
ACE= angiotensin-converting enzyme;  ARB = Angiotensin receptor blocker  
Bold = Significantly different between video-SMA and usual care groups.   
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FIGURE 1  
 
Flowchart of Study Inclusion Exclusion Criteria  
 
 
 
 
 
 
 
 
 
  
USUAL	  CARE	  
N	  =	  69	  (no	  SMA)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Diagnosis	  of	  DM	  &	  HbA1c	  
≥7%	  
INTERVENTION	  
N=	  31	  (SMA,	  6	  grps	  of	  4-­‐6	  
veterans)	  
Diagnosis	  of	  DM	  &	  HbA1c	  
≥7%	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FIGURE 2 
 
Consort Diagram of Participants 
 
 
 
 
 
  
Usual care 
Identified 227 patients from 
electronic medical records 
that met eligibility criteria 
Selected first 69 patients 
that were time-matched 
with intervention group 
Intervention 
Sent letters via mail to 118 
patients who met eligibility 
criteria 
Selected first 32 patients 
contacted by phone who 
consented to participate 
1 patient withdrawn 
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FIGURE 3 
 
 
 
 
 
 
Figure 3. Effect of video-SMA on HbA1c Levels over Duration of Study.HbA1c levels were 
measured in the video-SMA group at baseline, 1 month, 3 months, and 5 months. Values 
represent the mean ± SE. 
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